Top

Published in:

Open Access 01-12-2011 | Poster presentation

Efficacy and safety of tocilizumab in european children with systemic onset juvenile idiopathic arthritis

Authors: O Nemiche, R Dagner, P Quartier, R Cimaz, O Richer, P Pillet, M Hofer

Published in: Pediatric Rheumatology | Special Issue 1/2011

Excerpt

The anti- IL-6 Receptor monoclonal antibody Tocilizumab (TCZ) has demonstrated its efficacy in Japanese children with systemic onset juvenile idiopathic arthritis (SJIA). …

Title: Efficacy and safety of tocilizumab in european children with systemic onset juvenile idiopathic arthritis
Authors: O Nemiche
R Dagner
P Quartier
R Cimaz
O Richer
P Pillet
M Hofer
Publication date: 01-12-2011
Publisher: BioMed Central
Published in: Pediatric Rheumatology / Issue Special Issue 1/2011
Electronic ISSN: 1546-0096
DOI: https://doi.org/10.1186/1546-0096-9-S1-P135

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Efficacy and safety of tocilizumab in european children with systemic onset juvenile idiopathic arthritis

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Special Issue 1/2011

Sensitivity and specificity of current diagnostic guidelines in children with macrophage activation syndrome complicating systemic juvenile idiopathic arthritis

Reports to the UK Yellow Card Scheme 2000-2009 for medications used in paediatric rheumatology

A biopsychosocial approach to parents of children with juvenile idiopathic arthritis

Tocilizumab in JIA patients who have inadequate response to anti-tumour necrosis factor therapy

Phenotypic variation in familial chilblain lupus (FCL) and Aicardi-Goutières syndrome (AGS) associated with TREX1 mutation in 4 family members

Etoposide in patients with rheuma-associated hemophagocytic lymphohistiocytosis / macrophage activation syndrome